Concept Medical enrols first patient in balloon angioplasty trial
Florida healthtech firm Concept Medical has enrolled the first patient in its MAGICAL trial examining its sirolimus-coated balloon against traditional …
Post
-
-
Palisade Bio begins MAD cohorts of Phase Ia/b ulcerative colitis therapy trial
US-based biopharmaceutical company Palisade Bio has begun the multiple ascending dose (MAD) cohorts of its ongoing Phase Ia/b trial of …
-
HEOR explained: Improving healthcare decisions with real-world evidence
Health economics and outcomes research (HEOR) plays a vital role in healthcare decision-making, ensuring that treatments, drugs, and interventions are …
-
Boehringer Ingelheim announces Phase III schizophrenia failures
German healthcare giant Boehringer Ingelheim has announced that its drug iclepertin, designed for patients living with cognitive impairment as a …
-
Leading Sales and Marketing Intelligence Providers and Technology Solutions for the Clinical Trials Industry
Leading sales and marketing intelligence providers and technology solutions for the clinical trials industry: Introduction In the intricate and important world …
-
Avacta Therapeutics reports data from trial of AVA6000 for salivary gland cancer
UK-based biotechnology company Avacta Therapeutics has reported outcomes from the Phase Ia trial of AVA6000, a drug candidate for solid …
-
Ocugen doses first subject in Phase I trial of diabetic macular oedema treatment
US-based biotechnology company Ocugen has dosed the first subject in a multicentre Phase I trial of OCU200 for diabetic macular …
-
The biggest challenges clinical trials will face in 2025
It has been a turbulent time for the pharmaceutical industry – especially in regard to the clinical trial sector. From …
-
European supergroup launches to tackle diversity in clinical trials
A new pan-European initiative aimed at creating a new less fragmented and more democratic ecosystem for clinical trials across the …
-
German PEI approves enrolment in cohort 5 of Oncolytics’ pancreatic cancer trial
The Paul-Ehrlich-Institute (PEI) in Germany has granted approval to continue subject enrolment in cohort 5 of Oncolytics Biotech’s GOBLET trial, …
-
Sanofi to increase competition in atopic dermatitis market after Dupixent success
Sanofi's participation at the JP Morgan 43rd Annual Healthcare Conference on 14 January 2025 was marked by a comprehensive overview …
-
OS Therapies’s HER2 therapy prevents lung cancer recurrence in 33% patients
OS Therapies’s HER2-immunotherapy met the primary endpoint in a Phase IIb trial in patients with recurrent, fully resected, lung metastatic …
-
Mainstay Medical study demonstrates benefit of neurostimulation for back pain
Mainstay Medical’s one-year study of its neurostimulation system for the treatment of chronic low back pain (CLBP) has demonstrated the …
-
Designing clinical trials for a complex disease: pediatric obesity
The prevalence of obesity has increased rapidly worldwide in adults and children. In the US over 14 million children, including …
-
Sen-Jam reports positive outcomes from Phase II trial of Covid-19 therapeutic
Sen-Jam Pharmaceutical has reported positive preliminary outcomes from its Phase II trial of SJP-002C, its new therapeutic, aimed at treating …
